Steven Piantadosi, M.D., Ph.D.

Steven Piantadosi, M.D., Ph.D.

Director, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center,
Phase One Foundation Chair

Dr. Piantadosi leads Cedars-Sinai Medical Center’s programs in cancer research, treatment and education, enhance academic activities related to cancer, and bring together Cedars-Sinai’s cancer physicians and researchers for innovative collaborations.

Prior to joining Cedars-Sinai in April 2007, Dr. Piantadosi was professor of oncology at The Johns Hopkins University School of Medicine, and director of biostatistics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He also was professor of biostatistics and professor of epidemiology at the university’s Bloomberg School of Public Health. After earning his medical degree from the University of North Carolina and a doctorate in biomathematics from the University of Alabama at Birmingham, Dr. Piantadosi became a senior staff fellow at the National Cancer Institute.

Dr. Piantadosi is one of the world’s leading experts in the design and analysis of clinical trials for cancer research. In addition to advising both FDA and industry, he has served on external advisory boards for the National Institutes of Health and other prominent cancer programs and centers.

The author of more than 230 peer-reviewed scientific articles, Dr. Piantadosi currently serves as senior editor of the journal Clinical Cancer Research. He has published extensively on research results, clinical applications, and trial methodology. While his papers have contributed to many diverse areas of oncology, he has also collaborated on studies in disciplines outside cancer including lung disease, AIDS and degenerative neurological disease.

Dr. Piantadosi is the author of “Clinical Trials: A Methodologic Perspective,” which is widely considered a classic textbook for clinical trials. He has taught young investigators extensively in his own course in the Hopkins Graduate Training Program in Clinical Investigation, and through international venues such as the AACR/ASCO Workshop on Methods in Clinical Cancer Research. Dr. Piantadosi has held leadership roles with national cooperative oncology groups, including the New Approaches to Brain Tumors Consortium, and as a member of numerous clinical trial monitoring committees.